11 results

• CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks

  February 3, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit indicates that manufacturers knew of the risks of CTCL, yet failed to report them to patients or doctors.

• Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis

  January 12, 2026

  Irvin Jackson

  A Dupixent lawsuit claims that side effects of the eczema drug led to the development of a rare form of T-cell lymphoma.

• Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections

  December 30, 2025

  Irvin Jackson

  A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring.

• Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis

  December 19, 2025

  Irvin Jackson

  An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers.

• Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027

  December 11, 2025

  Irvin Jackson

  Parties in a Dupixent wrongful death lawsuit met with the presiding judge for the first time this week, indicating the case will be ready for trial by December 6, 2027.

• Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome

  December 5, 2025

  Irvin Jackson

  A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years.

• Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026

  December 2, 2025

  Irvin Jackson

  A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman's wrongful death lawsuit.

• Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits

  November 17, 2025

  Irvin Jackson

  Following what it says are promising clinical trial results, Sanofi is seeking yet another approved use for Dupixent, even as concerns grow over the drug's potential link to T-cell lymphoma.

• Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations

  October 29, 2025

  Irvin Jackson

  Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns.

• Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit

  October 17, 2025

  Irvin Jackson

  Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.